. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Genetically Modified Mice Susceptible to Pathogens Infection

Reference #:

2004-022

Inventors/Contributors

Roberto Cattaneo, Ph.D.

Description

Mice expressing human CD46 with human-like tissue specificity and efficiency. For additional information, please see the following: Mrkic et al., (1998). Measles virus spread and pathogenesis in genetically modified mice. Journal of Virology, volume 72, number 9, 7420-7427. Mrkic et al. (2000). Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. Journal of Virology, volume 74, number 3, 1364-1372.

Patent Status

None

Contact

Susan L. Stoddard, Ph.D., Licensing Manager
sstoddard@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-1222
Fax: (507) 284-5410